David Weaver
-
VU, GlaxoSmithKline team to develop novel treatments for severe obesity
Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity. Read MoreFeb 11, 2013
-
VU researcher has personal motive for investigating malaria
Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes. Read MoreFeb 3, 2012
-
Cancer study seeks clues to halting metastasis’ march
Vanderbilt researchers have identified small molecules that can restore normal protein expression in human colorectal carcinoma cells and prevent invasive cancer growth. Read MoreAug 10, 2011